Discover

BLFS
BioLife Solutions, Inc.
35.15
6 x 35.12
1 x 35.17
bid
ask
+
0.51
1.48%
01:35 PM
timesize
Ytd45.37%
1y57.14%
34.58
day range
35.16
17.86
52 week range
35.16
Open34.58Prev Close34.64Low34.58High35.16Mkt Cap1.72B
Vol139.71KAvg Vol1.12MEPS-0.21P/E-166.31Forward P/E105.03
Beta1.93Short Ratio2.70Inst. Own104.20%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg28.70200-d Avg24.571yr Est31.13

BLFS News

BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
zacks.com
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates

BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zack

BioLife Solutions Reports Second Quarter 2026 Financial Results
prnewswire.com
BioLife Solutions Reports Second Quarter 2026 Financial Results

Total revenue of $28.5 million, up 21% over Q2 2025 GAAP gross margin of 64% and non-GAAP adjusted g

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
businesswire.com
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,

Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
zacks.com
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout

RGEN's $1.5 billion BioLife acquisition aims to expand its cell therapy capabilities, adding biopres

Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
marketbeat.com
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach

Repligen NASDAQ: RGEN said it has signed a definitive agreement to acquire BioLife Solutions in a tr

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of  BioLife Solutions, Inc. (NASDAQ: BLFS)
gurufocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc.

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS)
prnewswire.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (

NEW YORK, July 22, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Ass

Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders
gurufocus.com
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price

Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price

Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders
prnewswire.com
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price

MILWAUKEE, July 22, 2026 /PRNewswire/ -- Ademi LLP is investigating BioLife (NASDAQ: BLFS) for possi

BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
gurufocus.com
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a F

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc.

Repligen Strengthens Cell Therapy Portfolio With BioLife Acquisition
benzinga.com
Repligen Strengthens Cell Therapy Portfolio With BioLife Acquisition

Life sciences company Repligen Corporation (NASDAQ:RGEN) on Wednesday agreed to acquire cell process

BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a F

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale

Repligen to buy cell therapy maker BioLife in $1.5 billion deal
reuters.com
Repligen to buy cell therapy maker BioLife in $1.5 billion deal

Repligen Corp said on ​Wednesday it would buy ‌BioLife Solutions in a cash-and-stock deal valued at

Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
globenewswire.com
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading B

Fast-tracks Repligen's leadership and customer solution offering in high-growth cell therapy market

10 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
10 Health Care Stocks With Whale Alerts In Today's Session

BioLife Solutions Inc (BLFS) Stock Up 3.1% and Still Undervalued -- GF Score: 73/100
gurufocus.com
BioLife Solutions Inc (BLFS) Stock Up 3.1% and Still Undervalued -- GF Score: 73/100

On May 28, 2026, BioLife Solutions Inc (BLFS) shares rose 3.1% to a current price of $25.25. This mo

BioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call Transcript
seekingalpha.com
BioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call Transcript

BioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call Transcript

BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates
zacks.com
BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates

BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zack

BioLife Solutions Reports First Quarter 2026 Financial Results
prnewswire.com
BioLife Solutions Reports First Quarter 2026 Financial Results

Total revenue of $27.5 million, up 25% over Q1 2025 GAAP gross margin and non-GAAP adjusted gross ma

4 Medical Product Stocks to Buy From a Challenging Industry
zacks.com
4 Medical Product Stocks to Buy From a Challenging Industry

The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026,

BioLife Solutions (NASDAQ:BLFS) Stock Crosses Below 200 Day Moving Average   – Time to Sell?
defenseworld.net
BioLife Solutions (NASDAQ:BLFS) Stock Crosses Below 200 Day Moving Average – Time to Sell?

BioLife Solutions, Inc. (NASDAQ: BLFS - Get Free Report) shares crossed below its 200-day moving ave

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

Earnings Scheduled For November 6, 2025
benzinga.com
Earnings Scheduled For November 6, 2025

benzinga.com
Earnings Scheduled For August 7, 2025

benzinga.com
Earnings Scheduled For May 8, 2025

benzinga.com
Earnings Scheduled For March 3, 2025

benzinga.com
Earnings Scheduled For November 12, 2024

benzinga.com
Earnings Scheduled For February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

benzinga.com
Earnings Scheduled For November 9, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

benzinga.com
Earnings Scheduled For August 8, 2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

benzinga.com
Earnings Scheduled For May 10, 2023

Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earn

benzinga.com
Earnings Scheduled For March 16, 2023

Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly

benzinga.com
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday

Gainers

benzinga.com
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day S

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wedn

benzinga.com
Earnings Scheduled For November 9, 2022

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear

benzinga.com
Earnings Scheduled For August 9, 2022

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 1043 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 849 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 242 companies hit new 52-week lows.

benzinga.com
Earnings Scheduled For February 28, 2022

  Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to repo

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

    During Tuesday's trading, 505 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

    On Thursday, 147 companies achieved new lows for the year.

benzinga.com
54 Biggest Movers From Yesterday

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46

benzinga.com
36 Stocks Moving In Wednesday's Mid-Day Session

Gainers

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

    Before 10 a.m. ET on Wednesday, 124 companies hit new 52-week highs.

benzinga.com
Earnings Scheduled For August 12, 2021

  Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report

benzinga.com
Stocks That Hit 52-Week Highs On Monday

    This morning 113 companies reached new 52-week highs.

benzinga.com
Earnings Scheduled For May 13, 2021

  Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

  Wednesday morning saw 335 companies set new 52-week highs.